DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells
3 p.-2 fig., Hutchinson-Gilford progeria syndrome (HGPS) is a rare disease caused by the expression of progerin, a mutant protein that accelerates aging and precipitates death. Given that atherosclerosis complications are the main cause of death in progeria, here, we investigated whether progerin-induced atherosclerosis is prevented in HGPSrev-Cdh5-CreERT2 and HGPSrev-SM22α-Cre mice with progerin suppression in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), respectively. HGPSrev-Cdh5-CreERT2 mice were undistinguishable from HGPSrev mice with ubiquitous progerin expression, in contrast with the ameliorated progeroid phenotype of HGPSrev-SM22α-Cre mice. To study atherosclerosis, we generated atheroprone mouse models by overexpressing a PCSK9 gain-of-function mutant. While HGPSrev-Cdh5-CreERT2 and HGPSrev mice developed a similar level of excessive atherosclerosis, plaque development in HGPSrev-SM22α-Cre mice was reduced to wild-type levels. Our studies demonstrate that progerin suppression in VSMCs, but not in ECs, prevents exacerbated atherosclerosis in progeroid mice., Work supported by grant PID2022- 141211OB- I00 funded by MICIU/AEI/10.13039/ 501100011033 and ERDF/EU. I.B. was supported by Comunidad de Madrid (2017- T1/BMD- 5247 and 2021- 5A/BMD- 20944) with cofunding from European Structural and Investment Fund, RYC2021- 033805- I (MICIU/AEI/10.13039/501100011033, European Union NextGenerationEU/PRTR), and PID2022- 137111OA- I00 (MICIU/AEI/10.13039/501100011033, ERDF/EU). Salary support to A.B. (BES- 2017- 079705, MICIU/AEI/10.13039/ 501100011033, ESF), C.E.- E. (Fundación “la Caixa”, LCF/BQ/DR19/1170012), R.M.N (Ministerio de Educación, Cultura y Deporte, FPU16/05027), and M.R.H. (MICIU, IJC2019- 040798- I). CNIC is supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia, Innovación y Universidades (MICIU), Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020- 001041- S funded by MICIU/AEI/10.13039/501100011033). Generation of anti- progerin antibody funded by Wellcome Trust (098291/Z/12/Z, 221699/Z/20/Z). Microscopy and Dynamic Imaging Unit- CNIC/ICTS- ReDib supported by ICTS- 2018- 04- CNIC- 16 funded by MICIU/AEI/10.13039/501100011033 and ERDF–A way to make Europe, Peer reviewed